Amgen's Patents on Cholesterol Drug Declared Valid

A jury declared valid two Amgen patents linked to the company’s recently approved cholesterol-lowering drug, delivering a setback to makers of a rival drug, Regeneron and Sanofi.

from WSJ.com: US Business http://ift.tt/1Z1vxi9
via IFTTT